Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Tetrabenazine

A VMAT2 transporter inhibitor that depletes dopamine and other monoamines stored in neurons: known since the 1950s, it was approved in the US in 2008 as the first authorised treatment for the chorea of Huntington's disease. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?In 2017 a version with six deuterium atoms in place of six hydrogens, deutetrabenazine, became the first deuterated drug approved in the United States.

TetrabenazineGo to the active ingredient →

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.